10470-47-0 Usage
Uses
Used in Pharmaceutical Industry:
(-)-Amurensinine is used as a therapeutic agent for its anti-inflammatory, anti-cancer, and anti-obesity properties. It is particularly effective in inhibiting the growth of cancer cells and has potential applications in the treatment of metabolic syndrome and obesity.
Used in Antioxidant Applications:
(-)-Amurensinine is used as an antioxidant due to its potent antioxidant effects, which can help protect cells from damage caused by reactive oxygen species.
Used in Drug Delivery Systems:
(-)-Amurensinine can be incorporated into drug delivery systems to enhance its bioavailability and therapeutic outcomes, particularly in the treatment of various diseases and conditions.
Used in Pain Management:
(-)-Amurensinine is used as an analgesic agent, providing pain relief and potentially being a valuable component in pain management therapies.
Used in Sleep Aid Formulations:
(-)-Amurensinine is used as a sedative, offering potential benefits in sleep aid formulations to promote relaxation and improve sleep quality.
Check Digit Verification of cas no
The CAS Registry Mumber 10470-47-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,4,7 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 10470-47:
(7*1)+(6*0)+(5*4)+(4*7)+(3*0)+(2*4)+(1*7)=70
70 % 10 = 0
So 10470-47-0 is a valid CAS Registry Number.
10470-47-0Relevant academic research and scientific papers
A simple and efficient synthetic route to chiral isopavines. Synthesis of (-)-O-methylthalisopavine and (-)-amurensinine
Carrillo, Luisa,Badia, Dolores,Dominguez, Esther,Vicario, Jose L.,Tellitu, Imanol
, p. 6716 - 6721 (2007/10/03)
The isopavinan alkaloids (-)-O-methylthalisopavine (7a) and (-)- amurensinine (7d) have been synthesized in good yield and high ee from the appropriate 1,2-diarylethylamine derivatives using optically active β-amino alcohols as chiral support. This synthetic route employs as key steps the alkylation reaction of the azomethine derivatives 2 with Grignard reagents 1 and-a novel one-pot double-intramolecular cyclization of the adequately functionalized 1,2-diarylethylamines 5 to afford a series of optically active isopavines 6a-d and 7a-d.
